scholarly journals Antibiotic Dosing in Slow Extended Daily Dialysis

2009 ◽  
Vol 49 (3) ◽  
pp. 433-437 ◽  
Author(s):  
David M. Mushatt ◽  
Linda B. Mihm ◽  
Albert W. Dreisbach ◽  
Eric E. Simon
1997 ◽  
Vol 1 (1) ◽  
pp. 12-18 ◽  
Author(s):  
Umberto Buoncristiani ◽  
Riccardo Fagugli ◽  
Giuseppe Quintaliani ◽  
Hrissanti Kulurianu
Keyword(s):  

Author(s):  
Silke Gastine ◽  
Yingfen Hsia ◽  
Michelle Clements ◽  
Charlotte IS Barker ◽  
Julia Bielicki ◽  
...  

1990 ◽  
Vol 10 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Maurice Levy ◽  
J. Williamson Balfe ◽  
Dennis Geary ◽  
Sue Fryer-Keene ◽  
Robert Bannatyne

A 10-year retrospective review of pediatric patients on peritoneal dialysis showed that 50 of 83 had 132 episodes of exit-site infection (ESI). Thirty-nine episodes were purulent. The most prevalent organism was Staphylococcus aureus. Staphylococcus epidermidis was also common, usually occurring in purulent infections. Gramnegative organisms were responsible for 23 ESls, with Pseudomonas species being the most common. Age, sex, concomitant primary disease type, length of training, dressing techniques, quality of daily dialysis technique, use of diapers, and pyelostomies did not affect the incidence of ESI. However, 40% of children with a skin infection from other sites had associated peritoneal catheter ESI. Thirty-eight episodes of ESI in 28 patients resulted in peritonitis; the main organisms involved were Staphylococcus and Pseudomonas species. Catheters were replaced in 13 patients with peritonitis, but there was no difference in the incidence of ESI before and after catheter replacement.


1992 ◽  
Vol 73 (3) ◽  
pp. 134-136 ◽  
Author(s):  
B. Watt ◽  
J.R. Edwards ◽  
A. Rayner ◽  
A.J. Grindey ◽  
G. Harris

2014 ◽  
Vol 99 (8) ◽  
pp. e3-e3
Author(s):  
J. Aston ◽  
D. Terry ◽  
B. Lambert ◽  
P. Patel

2010 ◽  
Vol 68 ◽  
pp. 158-158
Author(s):  
Y Liem ◽  
R Rozemeijer ◽  
T Krediet ◽  
A Fleer ◽  
T Egberts ◽  
...  
Keyword(s):  

Antibiotics ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 615
Author(s):  
Johanna Seeger ◽  
Sebastian Guenther ◽  
Katharina Schaufler ◽  
Stefan E. Heiden ◽  
Robin Michelet ◽  
...  

Minimal inhibitory concentration-based pharmacokinetic/pharmacodynamic (PK/PD) indices are commonly applied to antibiotic dosing optimisation, but their informative value is limited, as they do not account for bacterial growth dynamics over time. We aimed to comprehensively characterise the exposure–effect relationship of levofloxacin against Escherichia coli and quantify strain-specific characteristics applying novel PK/PD parameters. In vitro infection model experiments were leveraged to explore the exposure–effect relationship of three clinical Escherichia coli isolates, harbouring different genomic fluoroquinolone resistance mechanisms, under constant levofloxacin concentrations or human concentration–time profiles (≤76 h). As an exposure metric, the ‘cumulative area under the levofloxacin–concentration time curve’ was determined. The antibiotic effect was assessed as the ‘cumulative area between the growth control and the bacterial-killing and -regrowth curve’. PK/PD modelling was applied to characterise the exposure–effect relationship and derive novel PK/PD parameters. A sigmoidal Emax model with an inhibition term best characterised the exposure–effect relationship and allowed for discrimination between two isolates sharing the same MIC value. Strain- and exposure-pattern-dependent differences were captured by the PK/PD parameters and elucidated the contribution of phenotypic adaptation to bacterial regrowth. The novel exposure and effect metrics and derived PK/PD parameters allowed for comprehensive characterisation of the isolates and could be applied to overcome the limitations of the MIC in clinical antibiotic dosing decisions, drug research and preclinical development.


2012 ◽  
Vol 8 (4) ◽  
pp. 291-295
Author(s):  
Lucia Di Micco ◽  
Stefania Marzocco ◽  
Maria L. Sirico ◽  
Serena Torraca ◽  
Biagio Di Iorio

Sign in / Sign up

Export Citation Format

Share Document